Literature DB >> 10999948

Rapid relief of block by mecamylamine of neuronal nicotinic acetylcholine receptors of rat chromaffin cells in vitro: an electrophysiological and modeling study.

R A Giniatullin1, E M Sokolova, S Di Angelantonio, A Skorinkin, M V Talantova, A Nistri.   

Abstract

The mechanism responsible for the blocking action of mecamylamine on neuronal nicotinic acetylcholine receptors (nAChRs) was studied on rat isolated chromaffin cells recorded under whole-cell patch clamp. Mecamylamine strongly depressed (IC(50) = 0.34 microM) inward currents elicited by short pulses of nicotine, an effect slowly reversible on wash. The mecamylamine block was voltage-dependent and promptly relieved by a protocol combining membrane depolarization with a nicotine pulse. Either depolarization or nicotine pulses were insufficient per se to elicit block relief. Block relief was transient; response depression returned in a use-dependent manner. Exposure to mecamylamine failed to block nAChRs if they were not activated by nicotine or if they were activated at positive membrane potentials. These data suggest that mecamylamine could not interact with receptors either at rest or at depolarized level. Other nicotinic antagonists like dihydro-beta-erythroidine or tubocurarine did not share this action of mecamylamine although proadifen partly mimicked it. Mecamylamine is suggested to penetrate and block open nAChRs that would subsequently close and trap this antagonist. Computer modeling indicated that the mechanism of mecamylamine blocking action could be described by assuming that 1) mecamylamine-blocked receptors possessed a much slower, voltage-dependent isomerization rate, 2) the rate constant for mecamylamine unbinding was large and poorly voltage dependent. Hence, channel reopening plus depolarization allowed mecamylamine escape and block relief. In the presence of mecamylamine, therefore, nAChRs acquire the new property of operating as coincidence detectors for concomitant changes in membrane potential and receptor occupancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999948     DOI: 10.1124/mol.58.4.778

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

1.  Trapping blockage of muscle nicotinic cholinoreceptors by mecamilamine.

Authors:  A I Skorinkin; K B Ostroumov; A R Shaikhutdinova; R A Giniatullin
Journal:  Dokl Biol Sci       Date:  2004 Nov-Dec

2.  The mechanisms underlying modulation of the receptor-channel complex functioning by chlorhexidine.

Authors:  A R Shajhutdinova; E E Nikol'sky; R A Giniatullin; A I Skorinkin
Journal:  Dokl Biol Sci       Date:  2005 May-Jun

3.  Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Authors:  L Eugene Arnold; Michael G Aman; Jill Hollway; Elizabeth Hurt; Bethany Bates; Xiaobai Li; Cristan Farmer; Rene Anand; Susan Thompson; Yaser Ramadan; Craig Williams
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-04-26       Impact factor: 2.576

4.  Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor.

Authors:  Erika Cecon; Julie Dam; Marine Luka; Clément Gautier; Anne-Marie Chollet; Philippe Delagrange; Laurence Danober; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2019-05-20       Impact factor: 8.739

5.  Effects of benzothiazepines on human neuronal nicotinic receptors expressed in Xenopus oocytes.

Authors:  Francisco Sala; José Mulet; Luis Miguel Valor; Manuel Criado; Salvador Sala
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

6.  Nicotinic acetylcholine receptors do not mediate excitatory transmission in young rat carotid body.

Authors:  David F Donnelly
Journal:  J Appl Physiol (1985)       Date:  2009-09-17

Review 7.  Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.

Authors:  Silvia Di Angelantonio; Rashid Giniatullin; Valeria Costa; Elena Sokolova; Andrea Nistri
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  Bimodal action of protons on ATP currents of rat PC12 cells.

Authors:  Andrei Skorinkin; Andrea Nistri; Rashid Giniatullin
Journal:  J Gen Physiol       Date:  2003-06-16       Impact factor: 4.086

Review 9.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

10.  Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones.

Authors:  Silvia Di Angelantonio; Giorgio Bernardi; Nicola B Mercuri
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.